UBS Group »

Relay Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 186k 11.01
2023-09-30 $513k 61k 8.41
2023-06-30 $2.4M 195k 12.56
2023-03-31 $2.8M 171k 16.47
2022-12-31 $3.9M 263k 14.94
2022-09-30 $436k 20k 21.33
2022-06-30 $1.1M 65k 16.75
2022-03-31 $3.3M 117k 28.30
2021-12-31 $2.8M 94k 30.00
2021-09-30 $343k 11k 31.50
2021-06-30 $1.1M 31k 36.59
2021-03-31 $1.5M 43k 34.57
2020-12-31 $352k 8.4k 41.80
2020-09-30 $23k 539 42.67